Skip to main content
. 2011 Jan 26;32(5):1271–1276. doi: 10.1007/s00296-010-1765-y

Table 1.

Parameters k cat and K m as measured in the kinetic assay

RA sera (anti-hPAD4 emission signals [x106]) Purified total IgG Purified total IgG depleted from anti-hPAD4 antibodies Control depletion
K m [mM] k cat [s−1] k cat /K m [s−1 M−1] K m [mM] k cat [s−1] k cat /K m [s−1 M−1] K m [mM] k cat [s−1] k cat /K m [s−1 M−1]
Anti-PAD4-positive sera
 RA26 (1.59) 1.35 5.26 3,890 0.85 3.38 3,970 0.8 3.38 4,225
 RA35 (1.43) 1.60 3.75 2,340 1.60 3.75 2,340 1.60 3.75 2,340
 RA64 (1.59) 1.40 5.20 3,710 1.50 5.60 3,730 1.50 5.20 3460
 RA78 (1.02) 1.40 5.26 3,750 1.30 5.26 4,040 1.25 5.26 4,200
 RA99 (1.14) 1.00 3.38 3,380 1.25 3.00 2,400 1.30 3.00 2,300
Anti-PAD4-negative sera
 RA39 (0.023) 1.20 5.51 4,591 1.49 6.19 4,154 1.25 4.87 3,896
 RA55 (0.021) 1.50 4.50 3,000 1.75 3.60 2,050 1.45 3.38 2,330
Healthy control sera
 HC74 (0.032) 1.50 2.25 1,500 1.20 2.63 2,192 nd nd nd
 HC80 (0.016) 0.75 2.40 3,200 0.75 2.63 3,506 0.75 2.25 3,000
 HC89 (0.046) 1.20 3.38 2,810 1.20 3.00 2,500 1.20 3.00 2,500
 Buffer control (0.005) 0.90 2.63 2,900

Recombinant hPAD4 was incubated with purified IgG or with MOPS buffer. The values shown are from one representative experiment. Anti-hPAD4 emission signals were obtained in the hPAD4-specific fluorometric immunoassay